← Find more feeds

gsk.com

Press releases

Get the latest updates from Press releases directly as they happen.

Follow now 396 followers

Latest posts

Last updated 6 days ago

GSK announces Wendy Becker to join the Board as Non-Executive Director

6 days ago

Read full

Japan’s Ministry of Health, Labour and Welfare approves GSK’s Arexvy, the country’s first respiratory syncytial virus (RSV) vaccine for older adults

8 days ago

Read full

European Commission authorises ViiV Healthcare’s Apretude (cabotegravir long-acting and tablets) for HIV prevention

14 days ago

Read full

Ojjaara (momelotinib) approved in the US as the first and only treatment indicated for myelofibrosis patients with anaemia

18 days ago

Read full

GSK and Save the Children renew award-winning partnership, with focus on ‘zero dose’ children who have never received a vaccine

19 days ago

Read full

GSK regulatory submission for momelotinib for the treatment of myelofibrosis accepted for review by Japanese regulator

22 days ago

Read full

GSK’s regulatory submission accepted for review by Japanese regulator for use of Nucala (mepolizumab) in adults with chronic rhinosinusitis with nasal polyps

about 1 month ago

Read full

New Shingrix data demonstrate 100% vaccine efficacy in the prevention of shingles in adults aged 50 and over in China

about 1 month ago

Read full

New research published in Science highlights potential of a naturally occurring bacterium to help eradicate malaria

2 months ago

Read full

Jemperli (dostarlimab) plus chemotherapy approved in the US as the first new frontline treatment option in decades for dMMR/MSI-H primary advanced or recurrent endometrial cancer

2 months ago

Read full

Strong performance and momentum drive upgraded guidance

2 months ago

Read full

ViiV Healthcare’s cabotegravir for HIV prevention receives positive CHMP opinion from European Medicines Agency

2 months ago

Read full

Or log in

Everything you care about in one place

Press releases

Latest posts

GSK announces Wendy Becker to join the Board as Non-Executive Director

Japan’s Ministry of Health, Labour and Welfare approves GSK’s Arexvy, the country’s first respiratory syncytial virus (RSV) vaccine for older adults

European Commission authorises ViiV Healthcare’s Apretude (cabotegravir long-acting and tablets) for HIV prevention

Ojjaara (momelotinib) approved in the US as the first and only treatment indicated for myelofibrosis patients with anaemia

GSK and Save the Children renew award-winning partnership, with focus on ‘zero dose’ children who have never received a vaccine

GSK regulatory submission for momelotinib for the treatment of myelofibrosis accepted for review by Japanese regulator

GSK’s regulatory submission accepted for review by Japanese regulator for use of Nucala (mepolizumab) in adults with chronic rhinosinusitis with nasal polyps

New Shingrix data demonstrate 100% vaccine efficacy in the prevention of shingles in adults aged 50 and over in China

New research published in Science highlights potential of a naturally occurring bacterium to help eradicate malaria

Jemperli (dostarlimab) plus chemotherapy approved in the US as the first new frontline treatment option in decades for dMMR/MSI-H primary advanced or recurrent endometrial cancer

Strong performance and momentum drive upgraded guidance

ViiV Healthcare’s cabotegravir for HIV prevention receives positive CHMP opinion from European Medicines Agency

Try Feeder for free